Vimedimex Medi-Pharma JSC (HOSE:VMD)

Vimedimex Medi-Pharma JSC Ratios and Metrics

Market cap in millions VND. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 6, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	240,868	254,764	262,485	322,702	548,130	331,966
Market Cap Growth	-22.00%	-2.94%	-18.66%	-41.13%	65.12%	-13.31%
Enterprise Value	-47,917	84,183	68,425	845,554	674,751	462,574
Last Close Price	15600.00	16500.00	15251.93	17030.63	27316.06	15555.86
PE Ratio	8.22	10.33	10.30	9.27	27.41	8.95
PS Ratio	0.21	0.20	0.07	0.05	0.04	0.02
PB Ratio	0.57	0.61	0.62	0.77	1.38	0.96
P/TBV Ratio	0.76	0.83	0.81	0.97	1.76	1.02
P/FCF Ratio	1.15	2.18	47.36	0.46	-	2.50
P/OCF Ratio	1.13	2.05	12.00	0.46	-	2.04
EV/Sales Ratio	-	0.07	0.02	0.12	0.06	0.03
EV/EBITDA Ratio	-	3.69	1.27	16.45	3.93	2.27
EV/EBIT Ratio	-	13.61	1.95	26.30	4.42	2.48
EV/FCF Ratio	-0.23	0.72	12.35	1.21	-	3.48
Debt / Equity Ratio	-	-	-	-	1.54	1.00
Debt / EBITDA Ratio	-	-	-	-	3.56	1.69
Debt / FCF Ratio	-	-	-	-	-	2.59
Asset Turnover	-	0.77	1.44	1.65	1.78	2.10
Inventory Turnover	-	6.81	5.46	3.75	3.57	3.83
Quick Ratio	1.16	1.08	0.92	0.60	0.46	0.48
Current Ratio	1.34	1.23	1.15	1.08	1.03	1.01
Return on Equity (ROE)	-	5.86%	6.73%	8.62%	5.22%	10.85%
Return on Assets (ROA)	-	0.24%	0.89%	0.47%	1.38%	1.34%
Return on Invested Capital (ROIC)	-6.63%	3.78%	14.81%	4.81%	17.54%	32.69%
Return on Capital Employed (ROCE)	-1.10%	1.40%	7.90%	7.30%	36.30%	50.40%
Earnings Yield	12.17%	9.68%	9.71%	10.79%	3.65%	11.17%
FCF Yield	87.18%	45.78%	2.11%	215.96%	-80.73%	40.08%
Dividend Yield	12.82%	-	-	-	-	12.86%
Payout Ratio	102.94%	122.37%	118.43%	43.41%	200.38%	63.63%
Buyback Yield / Dilution	0.01%	0.01%	-0.02%	0.00%	0.00%	-
Total Shareholder Return	12.83%	0.01%	-0.02%	-	-	12.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.